June 2, 2015

Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations

Key Points

Key points are not available for this paper at this time.

Abstract

Biochemical profiling and subclassification of KRAS-driven cancers will enable the rational selection of therapies targeting specific KRAS isoforms or specific RAS effectors.

Bookmark

Cite This Study

Hunter et al. (Tue,) studied this question.

synapsesocial.com/papers/69de6ce4bf539e22705588d9 https://doi.org/https://doi.org/10.1158/1541-7786.mcr-15-0203

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1GAP control: regulating the regulators of small GTPases2004 · 307 citations
2Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.1982 · 804 citations
3Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers1998 · 167 citations
4<i>PHENIX</i>: a comprehensive Python-based system for macromolecular structure solution2010 · 24,544 citations
5Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene1982 · 957 citations

Bookmark